Combined Method for Induction of Labor

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

Induced Labor

See also
Status	Clinical Trial	Phase
Completed	`NCT00468520` - Adjuvant Oxytocin for Preinduction Ripening With a Foley catheter--a Clinical Trial	N/A
Completed	`NCT03744364` - Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor	Phase 4
Completed	`NCT01231126` - Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour	Phase 4
Terminated	`NCT00890630` - Intracervical Catheters for Induction of Labour in Women With Prelabour Rupture of Membranes at Term	Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT00468520 - Adjuvant Oxytocin for Preinduction Ripening With a Foley catheter--a Clinical Trial

N/A

Completed

NCT03744364 - Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor

Phase 4

Completed

NCT01231126 - Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour

Phase 4

Terminated

NCT00890630 - Intracervical Catheters for Induction of Labour in Women With Prelabour Rupture of Membranes at Term

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02685085
Study type	Interventional
Source	Woman's Health University Hospital, Egypt
Contact	Dina MR Dakhly, MD
Phone	01003498919
Email	dinadakhly@gmail.com
Status	Recruiting
Phase	Phase 2
Start date	February 2016
Completion date	August 2016

Combined Method for Induction of Labor

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms